Mode
Text Size
Log in / Sign up
N/A N=165 Randomized Double-blind Other

Acupuncture in the Emergency Department for Pain Management

Acupuncture · Pain Management · Emergency Department · Acute Pain

Enrolled (actual)
165
Serious AEs
0.7%
Results posted
Feb 2024
Primary outcome: Primary: Successful Recruitment of Participants Into the Study. — 26.1; 27.7; 16.3; 49.1 Percentage of participants enrolled

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Acupuncture for pain management (Procedure); Usual care for pain management (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Case Western Reserve University
Primary completion
Sep 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Successful Recruitment of Participants Into the Study.
26.1; 27.7; 16.3; 49.1
SECONDARY
Percentage of Participants Retained in the Study at Post Treatment
91.5; 98.4; 95.5; 80
SECONDARY
Percentage of Patients Retained at 1-week Follow up
77.6; 82.0; 81.6; 69.1
SECONDARY
Patient Satisfaction Question 1 at Post-treatment
3.91; 4.36; 3.46
SECONDARY
Patient Satisfaction Question 2 at Post-treatment
4.13; 4.57; 3.70
SECONDARY
Patient Satisfaction Question 1 at 1-Week
3.95; 4.16; 3.73
SECONDARY
Patient Satisfaction Question 2 at 1 Week
3.98; 4.19; 3.75
SECONDARY
Provider Satisfaction Question1
2.19
SECONDARY
Provider Satisfaction Question 2
2.50
SECONDARY
Provider Satisfaction Question 3
3.03
SECONDARY
Provider Satisfaction Que4
0.38

Summary

Our goal is to use the R01 mechanism to conduct a two-arm multisite, feasibility RCT (Acupuncture vs Usual Care) to refine procedures for conducting a future fully powered multi-site RCT. The effort will be led by the BraveNet Coordinating Center at Einstein and include 3 BraveNet PBRN sites University Hospitals/ Case Western Reserve University (UH/Case), Vanderbilt University Medical Center (VUMC), and University of California-San Diego (UCSD). During Year 1 (Aim 1), we will develop the manualized acupuncture intervention with consensus from experts in the delivery of acupuncture for acute pain. At the end of Year 1 (prior to the start of the RCT), a study investigator meeting will be held to ensure consistent training of all study coordinators and acupuncturists to the study data collection, human subjects, intervention delivery, and reporting requirements. In Year 2-3 (Aim 2), we will enroll 165 participants (55 per site) into the randomized trial (1:1 assignment to Acupuncture or Usual Care) over a ~9-month enrollment period for each site. Sites will participate in the study sequentially, thus general findings from the implementation evaluation may be used to improve implementation at subsequent sites. Treatment outcomes include pain intensity, state anxiety and pain medication utilization within the ED (via EHR data extraction). In Aim 2a, 75 structured qualitative interviews of ED providers, staff, study acupuncturists (~10 per site) and acupuncture patients (~15 per site) and direct observation at each site will be used to identify barriers and facilitators of successful implementation. The Implementation Evaluation includes two broad categories of data: implementation outcomes (collected in Aim 2 as the feasibility study is conducted at each site) and explanatory factors (Aim 2a).

Eligibility Criteria

Inclusion Criteria

  • Patients ≥18 years of age
  • Ability to communicate in English.
  • Level 3, 4, 5 on triage rate scale
  • Presentation with acute non-emergent (musculoskeletal, back, pelvic, non-cardiac chest, abdominal, flank or head) pain ≥4 on a 0-10-point NRS due to non-penetrating injury.

Exclusion Criteria

  • Fever exceeding 100° F
  • Presenting with a chief complaint of a psychological / psychiatric concern
  • Presenting with chief complaint of Migraine
  • Patient arriving via ambulance or skipping triage
  • Current Pregnancy
  • Self-reported opioid medication taken orally within 4 hours
  • Presenting with chief complaint of Joint Dislocation
  • Presenting with chief complaint of Bone Fracture
  • Confirmed or suspected COVID-19
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04880733). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search